Skip to main content

Providence Wealth Advisors, LLC

SEC CIK
0001744955
Latest filing
Jul 29, 2026

IMGN holding history

ImmunoGen, Inc. in every 13F filed by Providence Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMGN overviewAll 13F holders of IMGNFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
9
Since Q1 2021
Holdings of IMGN by Providence Wealth Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−10,000−100.0%Sold outHolders
Q1 202310,000$42.4K<0.1%00.0%UnchangedHolders
Q4 202210,000$44.0K<0.1%00.0%UnchangedHolders
Q3 202210,000$55.0K<0.1%00.0%UnchangedHolders
Q2 202210,000$51.0K<0.1%00.0%UnchangedHolders
Q1 202210,000$51.0K<0.1%00.0%UnchangedHolders
Q4 202110,000$67.0K<0.1%00.0%UnchangedHolders
Q3 202110,000$57.0K<0.1%00.0%UnchangedHolders
Q2 202110,000$63.0K<0.1%−2,500−20.0%ReducedHolders
Q1 202112,500$101.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.